Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Originally published as JCO Early Release 10.1200/JCO.2004.11.032 on December 2 2004

Journal of Clinical Oncology, Vol 22, No 24 (December 15), 2004: pp. 4979-4990
© 2004 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landier, W.
Right arrow Articles by Hudson, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landier, W.
Right arrow Articles by Hudson, M. M.

SPECIAL ARTICLE

Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline

Wendy Landier, Smita Bhatia, Debra A. Eshelman, Katherine J. Forte, Teresa Sweeney, Allison L. Hester, Joan Darling, F. Daniel Armstrong, Julie Blatt, Louis S. Constine, Carolyn R. Freeman, Debra L. Friedman, Daniel M. Green, Neyssa Marina, Anna T. Meadows, Joseph P. Neglia, Kevin C. Oeffinger, Leslie L. Robison, Kathleen S. Ruccione, Charles A. Sklar, Melissa M. Hudson

From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric Oncology, AFLAC Cancer Center and Blood Disorders Service, Children's Healthcare of Atlanta, Atlanta, GA; Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN; Children's Oncology Group Patient Advocacy Committee, Lincoln, NE; Department of Pediatrics, University of Miami School of Medicine, Miami, FL; Division of Pediatric Hematology-Oncology, University of North Carolina, Chapel Hill, NC; Department of Radiation Oncology, University of Rochester Medical Center, Rochester; Department of Pediatrics, Roswell Park Cancer Institute, Buffalo; Department of Pediatrics/Endocrinology, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Radiation Oncology, McGill University Health Centre, Montréal, Québec, Canada; Department of Pediatric Hematology-Oncology, Children's Hospital and Regional Medical Center, Seattle, WA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA; and Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis, MN

Address reprint requests to Melissa M. Hudson, MD, St Jude Children's Research Hospital, 332 N Lauderdale, Memphis, Tennessee 38105; e-mail: melissa.hudson{at}stjude.org

The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers are risk-based, exposure-related clinical practice guidelines intended to promote earlier detection of and intervention for complications that may potentially arise as a result of treatment for pediatric malignancies. Developed through the collaborative efforts of the Children’s Oncology Group Late Effects Committee, Nursing Discipline, and Patient Advocacy Committee, these guidelines represent a statement of consensus from a multidisciplinary panel of experts in the late effects of pediatric cancer treatment. The guidelines are both evidence-based (utilizing established associations between therapeutic exposures and late effects to identify high-risk categories) and grounded in the collective clinical experience of experts (matching the magnitude of risk with the intensity of screening recommendations). They are intended for use beginning 2 or more years following the completion of cancer therapy; however, they are not intended to provide guidance for follow-up of the survivor’s primary disease. A complementary set of patient education materials ("Health Links") was developed to enhance follow-up care and broaden the application of the guidelines. The information provided in these guidelines is important for health care providers in the fields of pediatrics, oncology, internal medicine, family practice, and gynecology, as well as subspecialists in many fields. Implementation of these guidelines is intended to increase awareness of potential late effects and to standardize and enhance follow-up care provided to survivors of pediatric cancer throughout the lifespan. The Guidelines, and related Health Links, can be downloaded in their entirety at www.survivorshipguidelines.org.

Supported by the Children's Oncology Group grant U10 CA098543 from the National Cancer Institute. Dr Hudson is also supported by the Cancer Center Support (CORE) grant CA 21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities.

Authors' disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
Ann OncolHome page
C. Simonelli, M. A. Annunziata, E. Chimienti, M. Berretta, and U. Tirelli
Cancer survivorship: a challenge for the European oncologists
Ann. Onc., July 1, 2008; 19(7): 1216 - 1217.
[Full Text] [PDF]


Home page
PediatricsHome page
K. Wasilewski-Masker, S. C. Kaste, M. M. Hudson, N. Esiashvili, L. A. Mattano, and L. R. Meacham
Bone Mineral Density Deficits in Survivors of Childhood Cancer: Long-term Follow-up Guidelines and Review of the Literature
Pediatrics, March 1, 2008; 121(3): e705 - e713.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. M. Shankar, N. Marina, M. M. Hudson, D. C. Hodgson, M. J. Adams, W. Landier, S. Bhatia, K. Meeske, M. H. Chen, K. E. Kinahan, et al.
Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group
Pediatrics, February 1, 2008; 121(2): e387 - e396.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. L. Friedman, A. Rovo, W. Leisenring, A. Locasciulli, M. E. D. Flowers, A. Tichelli, J. E. Sanders, H. J. Deeg, and G. Socie
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party
Blood, January 15, 2008; 111(2): 939 - 944.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. R. Carver, C. L. Shapiro, A. Ng, L. Jacobs, C. Schwartz, K. S. Virgo, K. L. Hagerty, M. R. Somerfield, D. J. Vaughn, and for the ASCO Cancer Survivorship Expert Panel
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
J. Clin. Oncol., September 1, 2007; 25(25): 3991 - 4008.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
P. C. Nathan, S. K. Patel, K. Dilley, R. Goldsby, J. Harvey, C. Jacobsen, N. Kadan-Lottick, K. McKinley, A. K. Millham, I. Moore, et al.
Guidelines for Identification of, Advocacy for, and Intervention in Neurocognitive Problems in Survivors of Childhood Cancer: A Report From the Children's Oncology Group
Arch Pediatr Adolesc Med, August 1, 2007; 161(8): 798 - 806.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. M. Geenen, M. C. Cardous-Ubbink, L. C. M. Kremer, C. van den Bos, H. J. H. van der Pal, R. C. Heinen, M. W. M. Jaspers, C. C. E. Koning, F. Oldenburger, N. E. Langeveld, et al.
Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer
JAMA, June 27, 2007; 297(24): 2705 - 2715.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. C. Oeffinger and L. L. Robison
Childhood Cancer Survivors, Late Effects, and a New Model for Understanding Survivorship
JAMA, June 27, 2007; 297(24): 2762 - 2764.
[Full Text] [PDF]


Home page
JCOHome page
R. Sposto, W. B. London, and T. A. Alonzo
Criteria for Optimizing Prognostic Risk Groups in Pediatric Cancer: Analysis of Data From the Children's Oncology Group
J. Clin. Oncol., May 20, 2007; 25(15): 2070 - 2077.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. S. Donaldson, M. P. Link, H. J. Weinstein, S. N. Rai, S. Brain, A. L. Billett, C. A. Hurwitz, M. Krasin, L. E. Kun, K. C. Marcus, et al.
Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease
J. Clin. Oncol., January 20, 2007; 25(3): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Goodwin, B. E. Oosterhuis, B. Hayes-Lattin, the LIVESTRONG Young Adult Alliance, N. Sharma, T. Melgar, C. Brands, R. Haupt, M. Jankovic, A. J.P. Veerman, et al.
Survivors of Childhood Cancer
N. Engl. J. Med., January 11, 2007; 356(2): 191 - 194.
[Full Text] [PDF]


Home page
JCOHome page
A. T. Meadows
Pediatric Cancer Survivorship: Research and Clinical Care
J. Clin. Oncol., November 10, 2006; 24(32): 5160 - 5165.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. C. Foster, R. A. Kleinerman, D. H. Abramson, J. M. Seddon, R. E. Tarone, and M. A. Tucker
Tobacco Use in Adult Long-term Survivors of Retinoblastoma.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1464 - 1468.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Maunsell, L. Pogany, M. Barrera, A. K. Shaw, and K. N. Speechley
Quality of Life Among Long-Term Adolescent and Adult Survivors of Childhood Cancer
J. Clin. Oncol., June 1, 2006; 24(16): 2527 - 2535.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. K. Gospodarowicz and R. M. Meyer
The Management of Patients with Limited-Stage Classical Hodgkin Lymphoma
Hematology, January 1, 2006; 2006(1): 253 - 258.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
B Jarzab, D Handkiewicz-Junak, and J Wloch
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
Endocr. Relat. Cancer, December 1, 2005; 12(4): 773 - 803.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. L. Spunt, T. A. Sweeney, M. M. Hudson, C. A. Billups, M. J. Krasin, and A. L. Hester
Late Effects of Pelvic Rhabdomyosarcoma and Its Treatment in Female Survivors
J. Clin. Oncol., October 1, 2005; 23(28): 7143 - 7151.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
S. Bhatia
Cancer Survivorship--Pediatric Issues
Hematology, January 1, 2005; 2005(1): 507 - 515.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online